Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Kay

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Archives of General Psychiatry|August 1, 1989
The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significanceS R Kay, M M Singh
The Psychiatric Quarterly|January 1, 1984
Values and therapy orientations of psychotherapy trainees: a twelve-year updateS R Kay, M M Vardy
Science (New York, N.Y.)|January 30, 1976
Wheat gluten as a pathogenic factor in schizophreniaM M Singh, S R Kay
The Journal of Nervous and Mental Disease|March 1, 1987
Outcome predictors in acute schizophrenia. Prospective significance of background and clinical dimensionsS R Kay, J P Lindenmayer
The Journal of Nervous and Mental Disease|April 1, 1975
Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significanceM M Singh, S R Kay
Psychopharmacologia|August 21, 1975
A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neurolepticsM M Singh, S R Kay
Perceptual and Motor Skills|February 1, 1975
Pulse rate and sleeplessness in relation to nosological distinctions in schizophreniaS R Kay, M M Singh
Neuropsychobiology|January 1, 1978
Nosological and prognostic distinctions in schizophrenia: pharmacological validation in terms of therapeutic antagonism between anticholinergic anti-parkinsonism drugs and neurolepticsM M Singh, S R Kay
Lancet (London, England)|September 25, 1976
Letter: Gluten and schizophreniaM M Singh, S R Kay
The American Journal of Psychiatry|February 1, 1989
Deficit or negative syndrome?S R Kay, L A Opler
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Archives of General Psychiatry|August 1, 1989
The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significanceS R Kay, M M Singh
The Psychiatric Quarterly|January 1, 1984
Values and therapy orientations of psychotherapy trainees: a twelve-year updateS R Kay, M M Vardy
Science (New York, N.Y.)|January 30, 1976
Wheat gluten as a pathogenic factor in schizophreniaM M Singh, S R Kay
The Journal of Nervous and Mental Disease|March 1, 1987
Outcome predictors in acute schizophrenia. Prospective significance of background and clinical dimensionsS R Kay, J P Lindenmayer
The Journal of Nervous and Mental Disease|April 1, 1975
Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significanceM M Singh, S R Kay
Psychopharmacologia|August 21, 1975
A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neurolepticsM M Singh, S R Kay
Perceptual and Motor Skills|February 1, 1975
Pulse rate and sleeplessness in relation to nosological distinctions in schizophreniaS R Kay, M M Singh
Neuropsychobiology|January 1, 1978
Nosological and prognostic distinctions in schizophrenia: pharmacological validation in terms of therapeutic antagonism between anticholinergic anti-parkinsonism drugs and neurolepticsM M Singh, S R Kay
Lancet (London, England)|September 25, 1976
Letter: Gluten and schizophreniaM M Singh, S R Kay
The American Journal of Psychiatry|February 1, 1989
Deficit or negative syndrome?S R Kay, L A Opler
Pageof 12